Skip to main content
. 2022 Jan 25;22:110. doi: 10.1186/s12885-021-08912-3

Fig. 6.

Fig. 6

Overall survival analyses of C1q in NSCLC. (A) NSCLC patients with elevated C1q (C1qa, C1qb, C1qc) levels had lower OS (p < 0.05). (B) LUAD patients with elevated C1q levels had lower OS (p < 0.05). (C) The levels of C1q had no correlation with prognosis of LUSC. (D) C1q including C1qa, C1qb and C1qc were positive correlative with α-SMA, COL1A1, CTGF and TGF-β1 in lung adenocarcinoma at TIMER2.0 database